The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.
The company has received final approval from the US Food and Drug Administration (USFDA) to market Decitabine for Injection in the strength of 50 mg/vial single-dose vial.
New Delhi: With talks underway between the central government and Zydus Cadila over the pricing of the Covid-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for.